Submit
Contact Us
Submit
Products
Product Overview
Carterra Ultra
Carterra LSA
XT
Carterra LSA
Sensor Chips & Solutions
Kinetics
TM
Analysis Software
Epitope
TM
Analysis Software
AI, ML & In Silico Tools
Testimonials
Applications
Overview
High Throughput Kinetics
Epitope Binning
Fc-Gamma Receptor
GPCR and Transmembrane Proteins
Quantitation
Antibody Epitope Mapping
Therapeutic Areas
Antibody Formats
Proximity-Based Degraders
DNA Encoded Library (DEL)
Kinase Inhibitors
Technology
Carterra HT-SPR™ Technology
SPR Overview
Attend SPR Camp
Testimonials
Frequently Asked Questions
Resources
Application Notes
Webinars and Videos
Podcasts
White Papers
Publications
Brochures & eBook
Posters
Symposia
2025
2024
2023
2022
2019
About Us
Overview
Management Team
Board of Directors
Testimonials
Careers
News
Blog
Events
Contact Us
Support
Inquiries
Customer Login
Application Training Program
Attend SPR Camp
Technical Support Updates
Store
Resource Center
Learn About Carterra and the LSA Platform
Peer-Reviewed Publication
Science: LY-CoV555, a Rapidly Isolated Potent Neutralizing Antibody, Provides Protection in a Non-Human Primate Model of SARS-CoV-2 Infection
Poster
Increasing DNA Encoded Library Screening Resolution Using HT-SPR
Application Note
High resolution FcRn IC
50
potency measurements using the Carterra
®
LSA
®
platform
Application Note
Profiling antibody polyreactivity and polyspecificity using HT-SPR on the Carterra
®
LSA
®
Webinar
The Transcendence of HT-SPR Technology Across Discovery Platforms and its Impact on Time-to-Clinic
Video • Webinar
FcRn Binding and Therapeutics Antibody Screening
Peer-Reviewed Publication
Absci achieves a breakthrough in AI drug creation
Peer-Reviewed Publication
Healthy humans can be a source of antibodies countering COVID-19
Peer-Reviewed Publication
Rapid discovery of diverse neutralizing SARS-CoV-2 antibodies from large-scale synthetic phage libraries
Webinar
Exploring Multicomponent COVID-19 Mutant Variant Analysis of Immunity Indicators in Human Serum
Webinar
HT-SPR Technology to Inform and Accelerate the Antibody Discovery Process
Webinar
Bispecific Antibodies Potently Neutralize SARS-CoV-2 Variants of Concern – Presentation by NIH Scientists
Webinar
The Transcendence of HT-SPR Technology Across Discovery Platforms and its Impact on Time-to-Clinic
Podcast
DDW Podcast: The Bamlanivimab story – how it reached the clinic in eight months
4
5
6
